184 related articles for article (PubMed ID: 9529655)
21. Complement activation by a B cell superantigen.
Kozlowski LM; Soulika AM; Silverman GJ; Lambris JD; Levinson AI
J Immunol; 1996 Aug; 157(3):1200-6. PubMed ID: 8757626
[TBL] [Abstract][Full Text] [Related]
22. B-cell self-tolerance in humans.
Wardemann H; Nussenzweig MC
Adv Immunol; 2007; 95():83-110. PubMed ID: 17869611
[TBL] [Abstract][Full Text] [Related]
23. B-cell superantigens: molecular and cellular implications.
Silverman GJ; Nayak JV; La Cava A
Int Rev Immunol; 1997; 14(4):259-90. PubMed ID: 9186781
[TBL] [Abstract][Full Text] [Related]
24. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells.
Phan TG; Amesbury M; Gardam S; Crosbie J; Hasbold J; Hodgkin PD; Basten A; Brink R
J Exp Med; 2003 Apr; 197(7):845-60. PubMed ID: 12668643
[TBL] [Abstract][Full Text] [Related]
25. Multiple paths to loss of anergy and gain of autoimmunity.
Conrad FJ; Rice JS; Cambier JC
Autoimmunity; 2007 Sep; 40(6):418-24. PubMed ID: 17729035
[TBL] [Abstract][Full Text] [Related]
26. Down-modulation of the antigen receptor by a superantigen for human B cells.
Viau M; Cholley B; Björck L; Zouali M
Immunol Lett; 2004 Mar; 92(1-2):91-6. PubMed ID: 15081532
[TBL] [Abstract][Full Text] [Related]
27. The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V(H) 3-23 and 3-30/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy.
Leucht S; Uttenreuther-Fischer MM; Gaedicke G; Fischer P
Clin Immunol; 2001 Apr; 99(1):18-29. PubMed ID: 11286538
[TBL] [Abstract][Full Text] [Related]
28. A B cell superantigen-induced persistent "Hole" in the B-1 repertoire.
Silverman GJ; Cary SP; Dwyer DC; Luo L; Wagenknecht R; Curtiss VE
J Exp Med; 2000 Jul; 192(1):87-98. PubMed ID: 10880529
[TBL] [Abstract][Full Text] [Related]
29. Silent antibodies.
Bouvet JP; Zouali M
Arch Inst Pasteur Tunis; 2005; 82(1-4):3-8. PubMed ID: 16929749
[TBL] [Abstract][Full Text] [Related]
30. [B cell superantigen].
Hakoda M
Ryumachi; 1997 Aug; 37(4):619-23. PubMed ID: 9311289
[No Abstract] [Full Text] [Related]
31. Essential Domain-Dependent Roles Within Soluble IgG for
Ulloa-Morales AJ; Goodyear CS; Silverman GJ
Front Immunol; 2018; 9():2011. PubMed ID: 30283436
[No Abstract] [Full Text] [Related]
32. B cell targeted therapy in autoimmunity.
Blank M; Shoenfeld Y
J Autoimmun; 2007; 28(2-3):62-8. PubMed ID: 17391915
[TBL] [Abstract][Full Text] [Related]
33. Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different immunological settings.
Ferraccioli G; Tolusso B
Autoimmun Rev; 2007 Dec; 7(2):109-13. PubMed ID: 18035319
[TBL] [Abstract][Full Text] [Related]
34. Nature and nurture of catalytic antibodies.
Paul S; Planque SA; Nishiyama Y; Hanson CV; Massey RJ
Adv Exp Med Biol; 2012; 750():56-75. PubMed ID: 22903666
[TBL] [Abstract][Full Text] [Related]
35. Effect of a putative B cell superantigen on complement.
Kozlowski LM; Lambris JD; Levinson AI
Ann N Y Acad Sci; 1995 Sep; 764():356-8. PubMed ID: 7486545
[No Abstract] [Full Text] [Related]
36. Structural basis of the gp120 superantigen-binding site on human immunoglobulins.
Karray S; Juompan L; Maroun RC; Isenberg D; Silverman GJ; Zouali M
J Immunol; 1998 Dec; 161(12):6681-8. PubMed ID: 9862697
[TBL] [Abstract][Full Text] [Related]
37. Naturally occurring B-cell autoreactivity: a critical overview.
Avrameas S; Ternynck T; Tsonis IA; Lymberi P
J Autoimmun; 2007 Dec; 29(4):213-8. PubMed ID: 17888629
[TBL] [Abstract][Full Text] [Related]
38. Adoptive transfer of a superantigen-induced hole in the repertoire of natural IgM-secreting cells.
Silverman GJ
Cell Immunol; 2001 Apr; 209(1):76-80. PubMed ID: 11414738
[TBL] [Abstract][Full Text] [Related]
39. Maintenance of antigen-specific immunological memory through variable regions of heavy and light chains of anti-idiotypic antibody.
Vani J; Nayak R; Shaila MS
Immunology; 2007 Apr; 120(4):486-96. PubMed ID: 17229267
[TBL] [Abstract][Full Text] [Related]
40. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
Dörner T
J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
